The Rare Disease Diagnostic Artificial Intelligence Consortium (RADIC) brings together a diverse group of stakeholders from industry, data science, patient advocacy, and academia with the mission to develop evidence-based consensus guidelines for the utilization of artificial intelligence (AI) in rare diseases. The guidelines aim to advance best practices and responsible use of AI for rare disease patient identification, epidemiological exploration, and phenotypic delineation.
2025 Events:
- March 19, 2025, in-person RADIC meeting at the American College of Medical Genetics Annual meeting
- June 26, 2025, Patrick Pavlick, Founder of Veridicus Advisory, The challenges and opportunities of using AI in rare disease diagnosis
- July 10, 2025, Ben Solomon, MD, Clinical Director at National Human Genome Research Institute, AI applications in medical genetics and genomics
- September 25 2025, Michael Kraft, MD, Medical Director – Virtual Care & Patient Access | Assistant Professor at Emory University, Challenges of rare diseases, the potential of utilizing big data to decrease the diagnostic odyssey
- October 23, 2025, Melissa Haendel, PhD, Director of Precision Health & Translational Informatics, Deputy Director of Computational Science at UNC Chapel Hill, Harmonizing electronic health record data and developing diagnostic tools for rare diseases
Upcoming Events in 2026:
- February 2026: RADIC Guest Speakers Series kicks off
- March 11, 2026: In-person RADIC meeting at the American College of Medical Genetics annual conference
- White Paper Publication — Implementing AI for Rare Disease Diagnostics — From Data to Clinical Reality
